↓ Skip to main content

Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients

Overview of attention for article published in Neurological Sciences, June 2018
Altmetric Badge

Mentioned by

twitter
6 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
38 Mendeley
Title
Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients
Published in
Neurological Sciences, June 2018
DOI 10.1007/s10072-018-3442-y
Pubmed ID
Authors

Bonaventura Casanova, Laura Lacruz, María Luisa Villar, José Andrés Domínguez, María Carcelén Gadea, Francisco Gascón, Javier Mallada, David Hervás, María Simó-Castelló, José Carlos Álvarez-Cermeño, Carmen Calles, Javier Olascoaga, Lluís Ramió-Torrentà, Carmen Alcalá, Angeles Cervelló, Isabel Boscá, Francisco Carlos Pérez-Mirallles, Francisco Coret

Abstract

To study the efficacy of interferon beta (IFNβ) and glatiramer acetate (GA) related to the presence of oligoclonal M bands (OCMB) in the cerebrospinal fluid in relapsing-remitting multiple sclerosis (RRMS). This is an observational, multicenter and retrospective study with prospectively collected data of patients that started treatment with IFNβ or GA. Treatment decision was made blinded to the OCMB status. Time to first attack after starting therapy was compared by using Kaplan-Meier curves, and adjustment by Cox regression analysis was performed. Two hundred and fifty-six patients entered in the study (141-55% received IFNβ; 115-45% received GA). After a mean follow-up of 41 and 65 months, 54.7% of patients remained free from further attacks (RF). The proportion of RF patients was higher in the GA group than in the IFNβ group (72.2 vs. 40.4%, p < 0.001). The IFNβ patients with OCMB+ presented the poorest response, 31.3% RF vs. 48.1% in IFNβ without OCMB, p = 0.03. OCMB in CSF could be a biomarker of treatment response in multiple sclerosis.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 21%
Researcher 7 18%
Student > Doctoral Student 4 11%
Other 3 8%
Student > Bachelor 2 5%
Other 7 18%
Unknown 7 18%
Readers by discipline Count As %
Medicine and Dentistry 15 39%
Neuroscience 4 11%
Arts and Humanities 1 3%
Psychology 1 3%
Unspecified 1 3%
Other 2 5%
Unknown 14 37%